载脂蛋白和脂蛋白与健康和疾病 2.0
Apolipoproteins and Lipoproteins in Health and Disease 2.0.
机构信息
Institut de Recerca Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
出版信息
Int J Mol Sci. 2024 Jun 4;25(11):6183. doi: 10.3390/ijms25116183.
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for 32% of global deaths, according to the World Health Organization (WHO) [...].
摘要
心血管疾病（CVDs）仍然是全球范围内的主要死因，占全球死亡人数的 32%，世界卫生组织（WHO）表示[... ]。
相似文献
1
Apolipoproteins and Lipoproteins in Health and Disease 2.0.载脂蛋白和脂蛋白与健康和疾病 2.0
Int J Mol Sci. 2024 Jun 4;25(11):6183. doi: 10.3390/ijms25116183.
2
Risk factors for the development of premature cardiovascular disease.早发性心血管疾病发生的风险因素。
Adv Exp Med Biol. 1985;183:27-36. doi: 10.1007/978-1-4613-2459-1_3.
3
The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.C-载脂蛋白在富含甘油三酯脂蛋白代谢中的作用。
Clin Sci (Lond). 1982 Feb;62(2):125-9. doi: 10.1042/cs0620125.
4
HDL proteome: new possibilities in the treatment of cardiovascular disease.高密度脂蛋白蛋白质组：心血管疾病治疗的新可能性。
Curr Vasc Pharmacol. 2012 Jul;10(4):391. doi: 10.2174/157016112800812773.
5
6
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus.脂蛋白和载脂蛋白在丙型肝炎病毒颗粒形成中的作用。
Trends Microbiol. 2015 Oct;23(10):618-629. doi: 10.1016/j.tim.2015.07.007.
7
Apolipoprotein function in health and disease: insights from natural mutations.载脂蛋白在健康与疾病中的功能：来自自然突变的见解
Eur J Clin Invest. 1996 Sep;26(9):733-46. doi: 10.1046/j.1365-2362.1996.2120536.x.
8
Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier.脂质、脂蛋白和载脂蛋白与血脑屏障的相互作用。
Pharm Res. 2021 Sep;38(9):1469-1475. doi: 10.1007/s11095-021-03098-6. Epub 2021 Sep 13.
9
Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins.人类载脂蛋白和脂蛋白的分子结构与代谢的当前概念。
Klin Wochenschr. 1981 Sep 15;59(18):1023-35. doi: 10.1007/BF01747745.
10
Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease.高甘油三酯血症：与心血管疾病风险增加相关的血浆脂蛋白变化。
Am J Cardiol. 1999 May 13;83(9B):3F-12F. doi: 10.1016/s0002-9149(99)00308-2.
引用本文的文献
1
Evaluation of the efficacy of integrating digital therapeutics with home-based cardiac rehabilitation on cardiovascular health in high-risk post-PCI patients (DTx-HBCR): Study protocol for a randomized controlled trial.评估数字疗法与家庭心脏康复相结合对高危PCI术后患者心血管健康的疗效（DTx-HBCR）：一项随机对照试验的研究方案
Digit Health. 2025 Jul 25;11:20552076251360885. doi: 10.1177/20552076251360885. eCollection 2025 Jan-Dec.
本文引用的文献
1
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.恩格列净联合或不联合依洛尤单抗对 2 型糖尿病患者 HDL 亚类的影响：EXCEED-BHS3 试验的事后分析。
Int J Mol Sci. 2024 Apr 8;25(7):4108. doi: 10.3390/ijms25074108.
2
The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial.地中海饮食与生活方式干预对代谢综合征患者脂蛋白亚类谱的影响：一项随机对照试验的结果
Int J Mol Sci. 2024 Jan 22;25(2):1338. doi: 10.3390/ijms25021338.
3
Interplay of Postprandial Triglyceride-Rich Lipoprotein Composition and Adipokines in Obese Adolescents.肥胖青少年餐后富含甘油三酯的脂蛋白组成与脂肪因子的相互作用。
Int J Mol Sci. 2024 Jan 16;25(2):1112. doi: 10.3390/ijms25021112.
4
Circadian Regulation of Apolipoproteins in the Brain: Implications in Lipid Metabolism and Disease.昼夜节律对脑内载脂蛋白的调节：在脂质代谢和疾病中的意义。
Int J Mol Sci. 2023 Dec 12;24(24):17415. doi: 10.3390/ijms242417415.
5
Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders.载脂蛋白 D 作为神经精神疾病的潜在生物标志物。
Int J Mol Sci. 2023 Oct 26;24(21):15631. doi: 10.3390/ijms242115631.
6
Different Dietary Sources of Selenium Alleviate Hepatic Lipid Metabolism Disorder of Heat-Stressed Broilers by Relieving Endoplasmic Reticulum Stress.不同硒源通过缓解内质网应激缓解热应激肉鸡的肝脏脂质代谢紊乱。
Int J Mol Sci. 2023 Oct 22;24(20):15443. doi: 10.3390/ijms242015443.
7
Advances in Treatment of Dyslipidemia.血脂异常治疗进展。
Int J Mol Sci. 2023 Aug 27;24(17):13288. doi: 10.3390/ijms241713288.
8
Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria.年龄、起源和功能研究导致加那利群岛家族性高胆固醇血症的常见 LDLR 突变。
Int J Mol Sci. 2023 Jul 11;24(14):11319. doi: 10.3390/ijms241411319.
9
Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients.二十碳五烯酸和二十二碳六烯酸补充剂可增加 n-3 脂肪酸中的高密度脂蛋白含量，并改善高甘油三酯血症患者的内皮功能。
Int J Mol Sci. 2023 Mar 11;24(6):5390. doi: 10.3390/ijms24065390.
Zotero 插件